Timing of antibiotic therapy in suspected sepsis
(1)
Within first hour
Systemic sclerosis variant associated with PAH
(2)
Limited cutaneous systemic sclerosis
Treatment for cyanide poisoning
(3)
Hydroxocobalamin
Ventilatory treatment of acute hypercapnic respiratory failure attributable to OHS
(4)
BPAP
Most sensitive test for small pleural effusions
(5)
Ultrasonography
Treatment for severe radiation pneumonitis
(6)
Glucocorticoids
Treatment for snoring and mild OSA
(7)
Weight loss
Timing of initiation of enteral nutrition in ICU
(8)
24-48 hours after admission
Glucocorticoid treatment for moderate to severe COPD exacerbation
(9)
Oral prednisone 40 mg for 5 days
Treatment for shock refractory to fluids and vasopressors
(10)
Hydrocortisone
Bedside tool to evaluate ICU-acquired weakness
(11)
Medical Research Council muscle scale
Role of sputum culture in COPD exacerbation
(12)
None
Empiric antibiotic class for bronchiectasis exacerbation
(13)
Fluoroquinolone
COPD indications for supplemental oxygen
PO2 ___ mm Hg, O2 saturation ___%
(14)
PO2 ≤55 mm Hg, O2 saturation ≤88%
Possible complication in air travel for patients with asthma or COPD
(15)
Pneumothorax
Recommended vaccinations for all patients with chronic lung disease
(16)
PPSV23 and annual influenza
Primary treatment for ARDS
(17)
Mechanical ventilation with PEEP
Nonventilatory oxygen support for acute hypoxemic respiratory failure
(18)
High-flow nasal cannula
ARDS tidal volume
(19)
4-8 mL/kg predicted body weight
Diagnostic tests for allergic bronchopulmonary aspergillosis
(20)
Aspergillus-specific IgE and IgG; Aspergillus antigen skin test
Pleural fluid pH and glucose level characteristic of complicated parapneumonic effusion
(21)
pH <7.2, glucose <60 mg/d
PDE-4 inhibitor to reduce severe COPD exacerbations and chronic bronchitis symptoms
(22)
Roflumilast
Prevention of extubation failure in high-risk patients
(23)
Early NPPV
Pulmonary infections suggestive of bronchiectasis
(24)
Pseudomonas aeruginosa, Aspergillus, non-TB mycobacteria
Contraindications to NPPV
(Atleast 3)
(25)
Altered mental status, increased secretions, vomiting, inability to protect airway